Found 0 matching trials
Paradoxical Reactions in Non Immuno-compromized Patients With Extrapulmonary Tuberculosis N/A Tuberculous paradoxical reactions (PR) are immune reactions occurring durin...
Show More Location
Georges Pompidou Hospital
Learn More & Join Trial
Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery PHASE2 RATIONALE: Studying samples of blood and tumor tissue from patients with ca...
Show More Location
Unversity of Nebraska Medical Center
Learn More & Join Trial
Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer N/A RATIONALE: Studying samples of tumor tissue from patients with cancer in th...
Show More Location
Multiple Locations
Learn More & Join Trial
HER-2 Mutations in Tumor Samples From Patients With Advanced Non-Small Cell Lung Cancer Treated on Clinical Trial ECOG-2598 N/A RATIONALE: Collecting samples of tumor tissue from patients with cancer to ...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymphomas PHASE2 Background:
* Studies conducted at the National Cancer Institute suggest t...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Decitabine and Tretinoin in Treating Patients With Myelodysplastic Syndromes PHASE1 RATIONALE: Drugs used in chemotherapy, such as decitabine, work in differen...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
ERA Test in Patients With Recurrent Implantation Failure NA The purpose of this study is to demonstrate the clinical efficiency of the ...
Show More Learn More & Join Trial
Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia N/A We will study gene and protein expression in leukemia cells of children dia...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
Technical Feasibility of the cfDNA Test for Non-invasive Cytogenetic Analysis of Early Miscarriages Versus the Gold Standard Microarray N/A Among the 15% of couples who experience a spontaneous early miscarriage (SE...
Show More Location
Hopital Femme-Mère-Enfant; service gynécologie/obstétrique
Learn More & Join Trial
Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin PHASE2 RATIONALE: Studying samples of blood in the laboratory from patients receiv...
Show More Location
Centre Paul Papin
Learn More & Join Trial